Recent Company News

• 04:59 PM ET Sep 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:18 AM ET Sep 16, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:42 AM ET Sep 16, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:34 AM ET Sep 16, 2025
  

  Brainsway issues press release on receipt of FDA Clearance for Accelerated Deep TMS Protocol for non-invasive treatment of Major Depressive Disorder (MDD) ($15.10, 0.00)

• 03:02 PM ET Sep 15, 2025
  

  FDA grants new clearance for BrainsWay Deep TMS System ($15.10, -0.67)

• 09:57 AM ET Aug 26, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (103 total)

• 10:02 AM ET Aug 22, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (87 total)

• 10:12 AM ET Aug 21, 2025
  

  BrainsWay Falters on New Investment

• 10:06 AM ET Aug 21, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (66 total)

• 09:33 AM ET Aug 21, 2025
  

  Neurolief Prepares for Launch of its Proliv"Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay